Reshaping the landscape of drug discovery with AI-Powered BCP
Our mission at Linnaeus Bioscience is dedicated to accelerating the antimicrobial discovery process and arming the global community in its battle against antibiotic resistant bacteria. Founded in 2012 based upon discoveries from the Pogliano Lab at the University of California, San Diego, Linnaeus Bioscience has developed bacterial cytological profiling (BCP) supported by in-house machine learning into a robust tool to enable new therapeutic breakthroughs.
More than a bioscience company
We are a solutions-oriented partner. Our involvement in diverse discovery and development projects underlines our wide range of expertise and our commitment to meet the unique and complex needs of our clients.
Our Team
JOE POGLIANO
Founder
KIT POGLIANO
Founder
MARC D. SHARP
Chief Scientific Officer
HANNAH TSUNEMOTO
Chief Operations Officer
DIANA QUACH
Chief Innovation Officer
JOE SUGIE
Chief Technology Officer
Scientific Advisory Board
KAREN JOY SHAW
LYNN L. SILVER
MICHAEL BARBACHYN
